Table 1 Demographic, clinical and treatment characteristics of mothers and neonates
NRDS (n = 55) | No NRDS (n = 79) | pvalue | |
|---|---|---|---|
Categorical | |||
Female (%) | 14/55 (25.5) | 37/78 (47.4) | 0.01 |
Smoking during pregnancy (%) | 1/48 (2.01) | 5/75 (6.7) | 0.250 |
Gestational diabetes (%) | 7/47 (14.9) | 11/74 (14.9) | 0.997 |
Thrombophilia (%) | 1/48 (2.1) | 3/75 (4.0) | 0.559 |
Caesarean section (%) | 32/55 (58.2) | 39/79 (49.4) | 0.315 |
Elective Caesarean (%) | 29/32 (90.1) | 21/39 (53.9) | 0.001 |
IUGR (%) | 1/51 (2.0) | 7/74 (9.5) | 0.092 |
Chorio-amnionitis (%) | 0/45 (0.0) | 1/74 (1.4) | 0.434 |
Oligo-hydramnios (%) | 2/45 (4.4) | 1/77 (1.3) | 0.279 |
Preeclampsia (%) | 1/50 (2.0) | 3/76 (4.0) | 0.542 |
Prenatal steroids (%) | 5/49 (10.2) | 9/76 (11.8) | 0.777 |
Fetal distress (%) | 16/49 (32.7) | 13/67 (19.4) | 0.104 |
Frequent OB visits (%) | 46/53(86.8) | 75/79(95.0) | 0.097 |
Blood transfusion (any) (%) | 40/55 (72.7) | 15/79 (18.9%) | < 0.001 |
Resuscitation at birth (%) | 24/52 (46.2) | 14/63 (22.2) | 0.007 |
Plasma transfusion (%) | 38/55 (69.1) | 12/79 (15.2%) | < 0.001 |
RBC transfusion (%) | 14/55 (25.4) | 4/79 (5.1%) | 0.001 |
Platelets transfusion (%) | 2/55 (3.6) | 1/79 (1.3%) | 0.362 |
Dopamine administration (%) | 33/55 (60.0) | 3/79 (3.8%) | < 0.001 |
Dobutamine administration (%) | 17/55 (30.9) | 1/79 (1.3%) | < 0.001 |
Continuous | |||
Gestational Age (weeks) | 38.3 (37.96, 38.62) | 38.6 (38.3–38.8) | 0.100* |
Birthweight (gr) | 3146 (3035, 3256) | 3160 (3044–3276) | 0.866 |
Maternal Age (years) | 31.1 (29.9, 32.3) | 30.8 (29.6–31.9) | 0.696 |
Maternal BMI (kg/m2) | 23.8 (22.1, 25.4) | 23.7 (22.4–25.1) | 0.970* |
pH | 7.31 (7.28,7.34) | 7.40 (7.37–7.42) | < 0.001 |
Base Excess | −6.72 (−7.78, −5.66) | −4.92 (− 5.58, − 4.26) | 0.004 |
Parenteral nutrition (days) | 8.24 (3.96, 12.52) | 1.51 (1.02, 1.99) | < 0.001 |
Intravenous Antibiotics (days) | 6.98 (6.38, 7.58) | 5.86 (4.58, 7.15) | 0.115 |
Apgar at 5 min | 8.92 (8.6–9.3) | 9.46 (9.2–9.7) | 0.002* |